Psychedelic Therapy for Eating Disorders
Anorexia nervosa, bulimia, and binge eating disorder are emerging targets in psychedelic research. Anorexia has one of the highest mortality rates of any psychiatric condition and responds poorly to existing treatments, making it a priority for novel approaches. Psilocybin trials at Johns Hopkins and University of California are in early phases, with promising signals around body image and psychological flexibility.
MDMA-assisted therapy is being explored for eating disorders given the high co-occurrence with trauma. Researchers hypothesize that MDMA's ability to reduce fear while increasing empathy and openness could help patients address the underlying trauma and distorted cognitions that drive disordered eating.
Clinical Trials
No trials found
There are currently no clinical trials for Eating Disorders in our database.